Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A group of influential doctors is calling on the NHS in England to use Roche's cancer drug Avastin (bevacizumab) off-label for a debilitating eye condition as it is a cheaper alternative to the patented medicines for the disease.
Clinical leaders from 120 Clinical Commissioning Groups, representing almost 60% of all CCGs, have come together to call on all stakeholders to remove the current barriers preventing CCGs from using the drug Avastin 'off- licence' to treat wet age-related macular degeneration (AMD).
This call is directed at the UK doctors' regulator the General Medical Council, the Department of Health and NHS England.
http://www.pmlive.com/pharma_news/uk_doctors_call_on_nhs_to_use_avastin_for_wet_amd_661157
Clinical leaders from 120 Clinical Commissioning Groups, representing almost 60% of all CCGs, have come together to call on all stakeholders to remove the current barriers preventing CCGs from using the drug Avastin 'off- licence' to treat wet age-related macular degeneration (AMD).
This call is directed at the UK doctors' regulator the General Medical Council, the Department of Health and NHS England.
http://www.pmlive.com/pharma_news/uk_doctors_call_on_nhs_to_use_avastin_for_wet_amd_661157